title: An autosomal genomic screen for dementia in an extended Amish family.
abstract: Apolipoprotein E (APOE) is the only universally confirmed susceptibility gene for late-onset Alzheimer disease (LOAD), although many loci are believed to modulate LOAD risk. The genetic homogeneity of isolated populations, such as the Amish, potentially provide increased power to identify LOAD susceptibility genes. Population homogeneity in these special populations may reduce the total number of susceptibility genes contributing to the complex disorder, thereby increasing the ability to identify any one susceptibility gene. Dementia in the Amish is clinically indistinguishable from LOAD in the general population. Previous studies in the Amish demonstrated a significantly decreased frequency of the APOE-4 susceptibility allele, but significant familial clustering of dementia [M.A. Pericak-Vance, C.C. Johnson, J.B. Rimmler, A.M. Saunders, L.C. Robinson, E.G. D'Hondt, C.E. Jackson, J.L. Haines, Alzheimer's disease and apolipoprotein E-4 allele in an Amish population, Ann. Neurol. 39 (1996) 700-704]. These data suggested that a genetic etiology independent of APOE may underlie the dementia observed in this population. In the present analysis, we focused on a large, multiplex, inbred Amish family (24 sampled individuals; 10 of whom are affected). We completed a genomic screen to identify novel LOAD loci (n=316 genetic markers), using both model-dependent "affecteds-only" analysis (dominant and recessive) and model-independent affected relative pair analysis. Interesting results (lod>1.5 or p<0.01) were obtained for markers on eight chromosomes (2q, 5q, 6q, 7p, 8p, 8q, 11p, 18p, 18q, and 19q). The highest overall score was a multipoint lod score of 3.1 on chromosome 11p. Most regions we identified were not previously detected by genomic screens of outbred populations and may represent population-specific susceptibilities to LOAD. These loci are currently under further investigation in a study of LOAD including additional Amish families.
authors.affiliation: Center for Human Genetics, Department of Medicine, Duke University Medical Center, 595 La Salle Street, Box 3445, Durham, NC 27710, USA. aakoch@chg.duhs.duke.edu
authors.forename: A E
authors.initials: AE
authors.lastname: Ashley-Koch
authors.forename: Y
authors.initials: Y
authors.lastname: Shao
authors.forename: J B
authors.initials: JB
authors.lastname: Rimmler
authors.forename: P C
authors.initials: PC
authors.lastname: Gaskell
authors.forename: K A
authors.initials: KA
authors.lastname: Welsh-Bohmer
authors.forename: C E
authors.initials: CE
authors.lastname: Jackson
authors.forename: W K
authors.initials: WK
authors.lastname: Scott
authors.forename: J L
authors.initials: JL
authors.lastname: Haines
authors.forename: M A
authors.initials: MA
authors.lastname: Pericak-Vance
mesh_terms: D000544:Alzheimer Disease / Q000453:epidemiology / Q000235:genetics; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics*; D002874:Chromosome Mapping; D002877:Chromosomes, Human / Q000235:genetics; D003704:Dementia / Q000453:epidemiology / Q000235:genetics*; D005006:Ethnicity; D005192:Family Health; D005260:Female; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D008126:Lod Score; D008958:Models, Molecular; D010375:Pedigree
chemical_list: D053327:Apolipoprotein E4; D001057:Apolipoproteins E